Evidence map›Paper›PMID 10194458›Full record

ReviewClinical microbiology reviews1999

Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome.

S Ladhani, C L Joannou, D P Lochrie, R W Evans, S M Poston

Open access · bronzeAbstract readReview
In one paragraph

Review in Clinical microbiology reviews, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed
8.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 325 citations in OpenAlex.

  1. Article
  2. Community-acquired staphylococcal scalded skin syndrome in an immunocompetent adult.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  3. The virulence toolkit of Staphylococcus aureus: a comprehensive review of toxin diversity, molecular mechanisms, and clinical implications.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Review
  4. Article
  5. Multidrug-ResistantInfection and drug resistance · 2025
    Article
  6. Article
  7. Article
  8. Molecular characterization and antibiotic resistance ofFood science and biotechnology · 2024
    Article
  9. Article
  10. Article
  11. Review
  12. Virulence Mechanisms of Staphylococcal Animal Pathogens.International journal of molecular sciences · 2023
    Review
  13. Species Profiles and Antimicrobial Resistance of Non-Food science of animal resources · 2023
    Article
  14. Clinical Impact ofAntibiotics (Basel, Switzerland) · 2023
    Review
  15. Antimicrobial Resistance, SCCAntibiotics (Basel, Switzerland) · 2023
    Article
  16. Article
  17. Review
  18. Adaptive Metabolism ofJournal of proteome research · 2022
    Article
  19. Article
  20. Article

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

S LadhaniDivision of Biomolecular Sciences, King's College London, London SE1 9RT, United Kingdom.DrShamez@aol.com
C L Joannou
D P Lochrie
R W Evans
S M Poston
King's College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The exfoliative (epidermolytic) toxins of Staphylococcus aureus are the causative agents of the staphylococcal scalded-skin syndrome (SSSS), a blistering skin disorder that predominantly affects children. Clinical features of SSSS vary along a spectrum, ranging from a few localized blisters to generalized exfoliation covering almost the entire body. The toxins act specifically at the zona granulosa of the epidermis to produce the characteristic exfoliation, although the mechanism by which this is achieved is still poorly understood. Despite the availability of antibiotics, SSSS carries a significant mortality rate, particularly among neonates with secondary complications of epidermal loss and among adults with underlying diseases. The aim of this article is to provide a comprehensive review of the literature spanning more than a century and to cover all aspects of the disease. The epidemiology, clinical features, potential complications, risk factors, susceptibility, diagnosis, differential diagnoses, investigations currently available, treatment options, and preventive measures are all discussed in detail. Recent crystallographic data on the toxins has provided us with a clearer and more defined approach to studying the disease. Understanding their mode of action has important implications in future treatment and prevention of SSSS and other diseases, and knowledge of their specific site of action may provide a useful tool for physiologists, dermatologists, and pharmacologists.

Indexed as

ChildChild, PreschoolDiagnosis, DifferentialExfoliatinsHumansInfantInfant, NewbornSkin Diseases, BacterialStaphylococcal InfectionsStaphylococcus aureusSuperantigensSyndromeExfoliatinsSuperantigens

Identifiers

PMID10194458
PMCPMC88916
OpenAlexW2120678768

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.